Theriva Biologics, Inc.

Quick facts

Phase 2 pipeline

• SYN-004
• SYN-010

Phase 1 pipeline

• Period 1 - Treatment Sequence AB
• Period 1 - Treatment Sequence AC
• Period 2 - Treatment Sequence AB
• Period 2 - Treatment Sequence AC
• SYN-020 Delayed Release Capsule

Competitive intelligence

For the full portfolio CI brief — phase mix, recent regulatory actions, upcoming PDUFA dates, patent timeline, class-overlap with competitors:

• Theriva Biologics, Inc. portfolio CI brief
• Theriva Biologics, Inc. pipeline updates RSS